Page last updated: 2024-10-26

diclofenac and Leukemia

diclofenac has been researched along with Leukemia in 1 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gottfried, E1
Lang, SA1
Renner, K1
Bosserhoff, A1
Gronwald, W1
Rehli, M1
Einhell, S1
Gedig, I1
Singer, K1
Seilbeck, A1
Mackensen, A1
Grauer, O1
Hau, P1
Dettmer, K1
Andreesen, R1
Oefner, PJ1
Kreutz, M1

Other Studies

1 other study available for diclofenac and Leukemia

ArticleYear
New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells.
    PloS one, 2013, Volume: 8, Issue:7

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport; Carcinoma; Cell Line, Tumor;

2013